NCT03641378View on ClinicalTrials.gov

Inpatient Palliative Care for Patients Undergoing Hematopoietic Stem Cell Transplantation

NACompletedINTERVENTIONAL
Enrollment

546

Participants

Timeline

Start Date

September 30, 2018

Primary Completion Date

July 1, 2022

Study Completion Date

July 1, 2023

Conditions
Stem Cell Transplant
Interventions
OTHER

Palliative Care Intervention

team of clinicians that specialize in the lessening (palliation) of many distressing symptoms

OTHER

Standard Transplant Care

Standard care per hospital guidelines

Trial Locations (3)

27705

Duke University, Durham

98109

Fred Hutchinson Cancer Research Center, Seattle

02215

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

Massachusetts General Hospital

OTHER

NCT03641378 - Inpatient Palliative Care for Patients Undergoing Hematopoietic Stem Cell Transplantation | Biotech Hunter | Biotech Hunter